FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Iodixanol (Visipaque) Injection
Status: Currently in Shortage
»Date first posted: 05/09/2022
»Therapeutic Categories: Medical Imaging

Expand all

GE Healthcare (Revised 06/06/2022)

Company Contact Information:
800-292-8514

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
NDC (0407-2223-23), 320 mg/1 mL, INJECTION, SOLUTION, IV Backordered. Product availability is likely to be impacted until the end of 2022. Impacted by Covid-related shutdown in China

GE Availability Update

Other
NDC (0407-2223-62), 320 mg/1 mL, INJECTION, SOLUTION, IV Backordered. Product availability is likely to be impacted until the end of 2022. Impacted by Covid-related shutdown in China.

GE Availability Update

Other
NDC (0407-2223-64), 320 mg/1 mL, INJECTION, SOLUTION, IV 10 BOTTLE, PLASTIC in 1 BOX > 100 mL in 1 BOTTLE, PLASTIC Partial supply. Full product availability is likely to be impacted until the end of July. Impacted by Covid-related shutdown in China; supply will gradually resume in the second half of 2022

GE Availability Update

Other
NDC (0407-2223-66), 320 mg/1 mL, INJECTION, SOLUTION, IV Backordered. Product availability is likely to be impacted until the end of 2022. Impacted by Covid-related shutdown in China.

GE Availability Update

Other
NDC (0407-2223-67), 320 mg/1 mL, INJECTION, SOLUTION, IV Backordered. Product availability is likely to be impacted until the end of 2022. Impacted by Covid-related shutdown in China.

GE Availability Update

Other
NDC (0407-2222-16), 270 mg/1 mL, INJECTION, SOLUTION, IV Backordered. Product availability is likely to be impacted until the end of 2022. Impacted by Covid-related shutdown in China.

GE Availability Update

Other
NDC (0407-2223-17), 320 mg/1 mL, VISIPAQUE INJECTION, SOLUTION, IV VISIPAQUE 320mgI/ml USB 10x100 VIAL ml USA Backordered. Product availability is likely to be impacted until the end of August. Impacted by Covid-related shutdown in China.

GE Availability Update

Other
NDC (0407-2222-19), 270 mg/1 mL, INJECTION, SOLUTION, IV Backordered. Product availability is likely to be impacted until the end of 2022. Impacted by Covid-related shutdown in China.

GE Availability Update

Other
NDC (0407-2222-21), 270 mg/1 mL, INJECTION, SOLUTION, IV Backordered. Product availability is likely to be impacted until the end of 2022. Impacted by Covid-related shutdown in China.

GE Availability Update

Other
NDC (0407-2223-16), 320 mg/1 mL, INJECTION, SOLUTION, IV Backordered. Product availability is likely to be impacted until the end of 2022. Impacted by Covid-related shutdown in China.

GE Availability Update

Other
NDC (0407-2223-17), 320 mg/1 mL, VISIPAQUE INJECTION, SOLUTION, IV VISIPAQUE 320mgI/ml USB 10x100 VIAL ml USA Partial supply. Full product availability is likely to be impacted until the end of July. Impacted by Covid-related shutdown in China; supply increasing through May and June

GE Availability Update

Other
NDC (0407-2223-19), 320 mg/1 mL, INJECTION, SOLUTION, IV Backordered. Product availability is likely to be impacted until the end of 2022. Impacted by Covid-related shutdown in China.

GE Availability Update

Other
NDC (0407-2223-21), 320 mg/1 mL, INJECTION, SOLUTION, IV Backordered. Product availability is likely to be impacted until the end of 2022. Impacted by Covid-related shutdown in China.

GE Availability Update

Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English